BioNxt Solutions Prepares for Human Bioequivalence Study For Multiple Sclerosis (MS)
Apr 23, 2025
VANCOUVER, BC / ACCESS Newswire / April 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is...